Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL29824737 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL6332969 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL263201 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL9474227 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL11054858 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL4111185 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL263200 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL191753 | 1.00 | TSHR (0.67) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL7804046 | 0.97 | TSHR (0.62) | TSHRLMNACYP3A4TDP1BLM | |
| Cadaverine Tartrate SCHEMBL4953538 | 0.97 | TSHR (0.62) | TSHRLMNACYP3A4TDP1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4689218-A | MIXTURE OF IBUPROFEN, ARGININE, SODIUM BICARBONATE, SODIUM BITARTRATE; VARIATIONS; FASTER ABSORPTION | ZAMBON S.P.A. (IT) | 1987-08-25 | — | — | US | claimed |
| US-6005005-A | MIXTURE OF ARGININE AND IBUPROFEN IN AQUEOUS SOLUTION AS ANTIINFLAMMATORY AGENTS | ZAMBON GROUP S.P.A. (IT) | 1999-12-21 | — | — | US | disclosed |
| EP-0710108-B1 | LIQUID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID | ZAMBON SPA (IT) | 1998-12-02 | — | — | EP | disclosed |
| EP-0710108-A1 | LIQUID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID | ZAMBON GROUP S.p.A. (IT) | 1996-05-08 | — | — | EP | disclosed |
| WO-1995000134-A1 | LIQUID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID | ZAMBON GROUP S.P.A. (IT) | 1995-01-05 | — | — | WO | disclosed |
| US-4689218-A | MIXTURE OF IBUPROFEN, ARGININE, SODIUM BICARBONATE, SODIUM BITARTRATE; VARIATIONS; FASTER ABSORPTION | ZAMBON S.P.A. (IT) | 1987-08-25 | — | — | US | disclosed |
| US-4689218-A | MIXTURE OF IBUPROFEN, ARGININE, SODIUM BICARBONATE, SODIUM BITARTRATE; VARIATIONS; FASTER ABSORPTION | ZAMBON S.P.A. (IT) | 1987-08-25 | — | — | US | disclosed |